✦ LIBER ✦

761 IDENTIFICATION AND PRECLINICAL PROFILE OF THE NOVEL HCV NS3 PROTEASE INHIBITOR BMS-650032

✍ Scribed by F. McPhee

Book ID: 117378845
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 50 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60763-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical Profile and Characterization

Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)

✍ McPhee, F.; Sheaffer, A. K.; Friborg, J.; Hernandez, D.; Falk, P.; Zhai, G.; Lev 📂 Article 📅 2012 🏛 American Society for Microbiology 🌐 English ⚖ 459 KB

63 CHARACTERIZATION OF VIROLOGIC ESCAPE

63 CHARACTERIZATION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1 NULL RESPONDERS RECEIVING A COMBINATION OF THE NS3 PROTEASE INHIBITOR BMS-650032 AND NS5A INHIBITOR BMS-790052

✍ F. McPhee; D. Hernandez; F. Yu; J. Ueland; C. Wang; H. Huang; D. Gardiner; R. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

778 PRECLINICAL PROPERTIES OF THE NOVEL

778 PRECLINICAL PROPERTIES OF THE NOVEL HCV NS3 PROTEASE INHIBITOR GS-9451

✍ A. Corsa; M. Robinson; H. Yang; B. Peng; G. Cheng; B. Schultz; O. Barauskas; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

779 PRECLINICAL CHARACTERIZATION OF THE

779 PRECLINICAL CHARACTERIZATION OF THE NOVEL HCV NS3 PROTEASE INHIBITOR GS-9256

✍ H. Yang; C. Yang; Y. Wang; G. Rhodes; M. Robinson; B. Schultz; O. Barauskas; B. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

14 DUAL ORAL THERAPY WITH THE NS5A INHIB

14 DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRIN

✍ F. Suzuki; K. Ikeda; J. Toyota; Y. Karino; T. Ohmura; K. Chayama; S. Takahashi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 117 KB

750 PRECLINICAL PHARMACOKINETIC PROFILE

750 PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITOR

✍ S.S. Good; X.-R. Pan-Zhou; M. Larsson; S. Luo; J.R. Selden; H. Rashidzadeh; S. B 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB